Return to search results
Evans_2022_PFAS_in-vitro_manuscript_ScienceHub_2022-6-24
Dataset of medium throughput (96 well plate) in vitro nuclear receptor activation assays for peroxisome proliferator activated receptor alpha (PPARa), PPAR gamma (PPARg), and estrogen receptor (ER) across a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals.
This dataset is associated with the following publication:
Evans, N., J. Conley, M. Cardon, P. Hartig, E. Medlock Kakaley, and L. Gray. In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor. TOXICOLOGY AND APPLIED PHARMACOLOGY. Academic Press Incorporated, Orlando, FL, USA, 449(116136): 1, (2022).
Resources
1 resource available
-
Evans_PFAS_in_vitro_manuscript_ScienceHub_dataset_2022-6-24.docx
APPLICATION/VND.OPENXMLFORMATS-OFFICEDOCUMENT.WORDPROCESSINGML.DOCUMENT
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[ "020:00" ] |
| contactPoint |
{ "fn": "Justin Conley", "hasEmail": "mailto:conley.justin@epa.gov" } |
| describedBy | https://pasteur.epa.gov/uploads/10.23719/1526555/documents/Evans_PFAS_in_vitro_manuscript_ScienceHub_dataset_dictionary_2022-6-24.docx |
| describedByType | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| description | Dataset of medium throughput (96 well plate) in vitro nuclear receptor activation assays for peroxisome proliferator activated receptor alpha (PPARa), PPAR gamma (PPARg), and estrogen receptor (ER) across a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals. This dataset is associated with the following publication: Evans, N., J. Conley, M. Cardon, P. Hartig, E. Medlock Kakaley, and L. Gray. In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor. TOXICOLOGY AND APPLIED PHARMACOLOGY. Academic Press Incorporated, Orlando, FL, USA, 449(116136): 1, (2022). |
| distribution |
[ { "title": "Evans_PFAS_in_vitro_manuscript_ScienceHub_dataset_2022-6-24.docx", "mediaType": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "downloadURL": "https://pasteur.epa.gov/uploads/10.23719/1526555/Evans_PFAS_in_vitro_manuscript_ScienceHub_dataset_2022-6-24.docx" } ] |
| identifier | https://doi.org/10.23719/1526555 |
| keyword |
[ "Adverse Outcome Pathways (AOPs)", "Children's Environmental Health", "PFAS", "bioactivity", "in vitro", "screening" ] |
| license | https://pasteur.epa.gov/license/sciencehub-license.html |
| modified | 2022-06-24 |
| programCode |
[ "020:000" ] |
| publisher |
{ "name": "U.S. EPA Office of Research and Development (ORD)", "subOrganizationOf": { "name": "U.S. Environmental Protection Agency", "subOrganizationOf": { "name": "U.S. Government" } } } |
| references |
[ "https://doi.org/10.1016/j.taap.2022.116136" ] |
| rights |
null
|
| title | Evans_2022_PFAS_in-vitro_manuscript_ScienceHub_2022-6-24 |
